Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

MLA

Naumann, F. V., et al. “Tamoxifen Induces Radioresistance through NRF2-Mediated Metabolic Reprogramming in Breast Cancer.” Cancer & Metabolism, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373388600&authtype=sso&custid=ns315887.

APA

Naumann, F. V., Sweep, F. C. G. J., Adema, G. J., Peeters, W. J. M., Martens, J. W. M., Bussink, J., & Span, P. N. (2023). Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer. Cancer & Metabolism.

Chicago

Naumann, F.V., F.C.G.J. Sweep, G.J. Adema, W.J.M. Peeters, J.W.M. Martens, J. Bussink, and P.N. Span. 2023. “Tamoxifen Induces Radioresistance through NRF2-Mediated Metabolic Reprogramming in Breast Cancer.” Cancer & Metabolism. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373388600&authtype=sso&custid=ns315887.